Skip to content
Recall Observatory FDA recall evidence

Drug product

Tremfya (guselkumab) Injection, 100 mg/mL, one single-dose prefilled syringe per carton, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044; NDC 57894-640-01.

D-0314-2021

March 09, 2021

Class III

Product summary

Firm
Cardinal Health Inc.
Event
Event 87489
Status
Terminated
Classification
Class III
Quantity
48 boxes
Official record key
drug-enforcement:D-0314-2021

Official wording

Reason: Temperature Abuse

Code information: KESOY.AI Exp. 04/2022

Distribution pattern: AL, LA, MS, TN

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Temperature Abuse